Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Cash flows from operating activities:
Net income	$ 980,918	$ 791,149
Adjustments to reconcile net income to net cash provided by operating activities -
Amortization of deferred financing costs	29,739	30,813
Depreciation	1,146	1,058
Non cash compensation expense	3,266	3,266
Changes in operating assets and liabilities:
Interest receivable on loans	37,068	(38,647)
Other assets	(27,088)	(20,594)
Accounts payable and accrued expenses	(23,286)	(22,927)
Deferred origination fees	22,252	10,607
Net cash provided by operating activities	1,024,015	754,725
Cash flows from investing activities:
Issuance of short term loans	(11,000,000)	(9,556,000)
Collections received from loans	10,067,500	9,107,000
Net cash used in investing activities	(932,500)	(449,000)
Cash flows from financing activities:
Proceeds from line of credit, net	849,559	734,199
Dividend paid	(891,983)	(813,503)
Cash restricted for reduction of line of credit		(202,061)
Net cash used in financing activities	(42,424)	(281,365)
Net increase in cash and cash equivalents	49,091	24,360
Cash and cash equivalents, beginning of period	136,441	96,299
Cash and cash equivalents, end of period	185,532	120,659
Supplemental Cash Flow Information:
Interest paid during the period	$ 364,292	$ 192,231